RESULTS
TIA, tachycardia, sinus arrest, acute coronary syndrome
RECURRENCES, RECURRENCE, TRANSIENT ISCHEMIC ATTACK, SINUS ARREST, COLLAPSE, ACUTE CORONARY SYNDROME, RECTAL BLEEDING, ATRIAL FIBRILLATION, TIA
Of the 437 patients (mean age 65 ± 11 years, 40.3% female) included in the RACE 7 ACWAS trial, 335 patients (mean age 65 ± 11 years, 41.8% female) used the ECG‐based handheld mHealth device. The remaining patients did not use the device due to unavailability at the time of inclusion. The mHealth monitoring identified 99 patients (29.6%, mean age 67 ± 10 years, 39.4% female) with at least one AF recurrence in the first 4 weeks, who were included in the current analysis. Baseline characteristics of these patients are presented in Table Characteristics of patients per randomization group.
Abbreviations: AF, atrial fibrillation; BMI, body mass index; bpm, beats per minute; ECG, electrocardiogram; ED, emergency department; HR, heart rate; TIA, transient ischemic attack.One patient was admitted because of suspected acute coronary syndrome with negative analysis (D), one patient was admitted for observation of a broad complex tachycardia after flecainide administration (D), one patient was admitted for observation of a collapse before discharge (E), one patient was admitted for colonoscopy because of rectal bleeding after initiation of anticoagulation (D) and one patient had a sinus arrest after flecainide infusion for an AF recurrence for which 30 seconds of compressions were performed, after which cardiac output was restored (D). Abbreviations: D = delayed cardioversion group, E = early cardioversion group.Patients with a median heart rate <110 bpm during AF recurrences had lower heart rates on the index ECG (106 [95–127] vs. 137 [119–152], 